Why Is End-of-Life Spending So High? Evidence from Cancer Patients
<jats:title>Abstract</jats:title> <jats:p>We study the sources of high end-of-life spending for cancer patients. Even among patients with similar initial prognoses, spending in the year post diagnosis is over twice as high for those who die within the year than those who survive. E...
Main Authors: | Zeltzer, Dan (Author), Einav, Liran (Author), Finkelstein, Amy (Author), Shir, Tzvi (Author), Stemmer, Salomon M (Author), Balicer, Ran D (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
MIT Press - Journals,
2022-08-26T17:37:40Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Can targeting high-risk patients reduce readmission rates? Evidence from Israel
by: Efrat Shadmi, et al.
Published: (2020-01-01) -
Bunching at the kink: Implications for spending responses to health insurance contracts
by: Einav, Liran, et al.
Published: (2019) -
The Response of Drug Expenditure to Nonlinear Contract Design: Evidence from Medicare Part D *
by: Einav, Liran, et al.
Published: (2018) -
Paying on the Margin for Medical Care: Evidence from Breast Cancer Treatments
by: Einav, Liran, et al.
Published: (2017) -
Selection in Insurance Markets: Theory and Empirics in Pictures
by: Einav, Liran, et al.
Published: (2011)